(in € thousands) |
December 31, 2019 |
January 31, 2019 |
Net income before minority interests |
(20,946) |
3,334 |
Share of profits of associates |
(32) |
(106) |
Amortization and provisions (1) |
8,882 |
4,353 |
Net impact of capitalization of research & development costs |
(1,300) |
(2,679) |
Income taxes (current and deferred) |
(3,446) |
2,505 |
Income taxes paid |
(1,980) |
(1,736) |
Unrealized financial gains and losses |
120 |
(370) |
Share-based payment transactions |
690 |
751 |
Gains (losses) on sales of assets |
114 |
(6) |
OPERATING CASH FLOW |
(17,879) |
6,046 |
Trade receivables |
19,446 |
(442) |
Trade payables |
(293) |
(1,066) |
Other receivables and other liabilities |
(865) |
5,582 |
Change in working capital requirement |
18,288 |
4,074 |
NET CASH FROM OPERATING ACTIVITIES |
409 |
10,120 |
Purchase of intangibles assets |
(642) |
(796) |
Purchase of property, plant and equipment |
(1,340) |
(3,395) |
Proceeds from the sale of assets |
- |
8 |
Acquisitions de subsidiaries, net of cash acquired |
(795) |
(4) |
Other investment operations |
(7) |
(2,425) |
NET CASH USED FOR INVESTING ACTIVITIES |
(2,784) |
(6,613) |
Purchase of intangible assets |
14,422 |
46,165 |
Repayment of borrowings (1) |
(10,148) |
(46,669) |
Proceeds from issue of shares |
17 |
40 |
Purchase and proceeds from disposal of treasury shares |
22 |
(131) |
Dividends paid |
- |
(89) |
NET CASH USED FROM FINANCING ACTIVITIES |
4,312 |
(684) |
Effect of exchange rate changes on cash and cash equivalents |
216 |
(456) |
INCREASE/(DECREASE) IN CASH AND CASH EQUIVALENTS |
2,153 |
2,367 |
Opening cash position |
18,087 |
15,720 |
Closing cash position |
20,241 |
18,087 |
NET CHANGE IN CASH AND CASH EQUIVALENTS |
2,154 |
2,367 |